ly 134046 has been researched along with yohimbine in 3 studies
| Studies (ly 134046) | Trials (ly 134046) | Recent Studies (post-2010) (ly 134046) | Studies (yohimbine) | Trials (yohimbine) | Recent Studies (post-2010) (yohimbine) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 5,893 | 253 | 532 |
| Protein | Taxonomy | ly 134046 (IC50) | yohimbine (IC50) |
|---|---|---|---|
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.0353 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1.02 | |
| D(2) dopamine receptor | Homo sapiens (human) | 2.06 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.0428 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.0466 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.126 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.0682 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 1.013 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.126 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.074 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.3 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 1.689 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crawley, JN; Hsiao, JK; Lawrenz, AL; Mefford, IN | 1 |
| Ganong, WF; Steele, MK | 1 |
| Guchhait, RB; Perry, BD; Stolk, JM; U'Prichard, DC; Vantini, G | 1 |
3 other study(ies) available for ly 134046 and yohimbine
| Article | Year |
|---|---|
Activation in young rats induced by LY134046, an inhibitor of phenylethanolamine N-methyltransferase.
Topics: Animals; Benzazepines; Exploratory Behavior; Female; Male; Motor Activity; Phenylethanolamine N-Methyltransferase; Rats; Rats, Inbred Strains; Time Factors; Yohimbine | 1989 |
Effects of catecholamine-depleting agents and receptor blockers on basal and angiotensin II- or norepinephrine-stimulated luteinizing hormone release in female rats.
Topics: Angiotensin II; Animals; Benzazepines; Catecholamines; Ditiocarb; Dopamine beta-Hydroxylase; Female; Gonadotropin-Releasing Hormone; Luteinizing Hormone; Ovariectomy; Phenylethanolamine N-Methyltransferase; Prazosin; Propranolol; Rats; Saralasin; Yohimbine | 1986 |
Assessment of the functional role of brain adrenergic neurons: chronic effects of phenylethanolamine N-methyltransferase inhibitors and alpha adrenergic receptor antagonists on brain norepinephrine metabolism.
Topics: Adrenergic alpha-Antagonists; Animals; Benzazepines; Brain; Female; Isoquinolines; Norepinephrine; Phenylethanolamine N-Methyltransferase; Prazosin; Rats; Rats, Inbred F344; Tetrahydroisoquinolines; Tissue Distribution; Tyrosine 3-Monooxygenase; Yohimbine | 1984 |